Typically emerging in the second and third trimester, GDM is associated with pancreatic β-cell dysfunction or delayed response to glucose levels and substantial insulin resistance second to placental hormonal release [2,3,4,5,6,7,8,9,10,11,12,13]. Here, INS is linked to gestational diabetes.